Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network

[Display omitted] Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorab...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 24; no. 16; pp. 3513 - 3520
Main Authors Sciabola, Simone, Goetz, Gilles H., Bai, Guoyun, Rogers, Bruce N., Gray, David L., Duplantier, Allen, Fonseca, Kari R., Vanase-Frawley, Michelle A., Kablaoui, Natasha M.
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 15.08.2016
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract [Display omitted] Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework.
AbstractList [Display omitted] Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework.
Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework.
Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and trust. The pharmaceutical development of OT as an oral peptide therapeutic has been hindered historically by its unfavorable physicochemical properties, including molecular weight, polarity and number of hydrogen bond donors, which determines poor cell permeability. Here we describe the first systematic study of single and multiple N-methylations of OT and their effect on physicochemical properties as well as potency at the OT receptor. The agonist EC50 and percent effect for OTR are reported and show that most N-methylations are tolerated but with some loss in potency compared to OT. The effect of N-methylation on exposed polarity is assessed through the EPSA chromatographic method and the results validated against NMR temperature coefficient experiments and the determination of NMR solution structures. We found that backbone methylation of residues not involved in IMHB and removal of the N-terminal amine can significantly reduce the exposed polarity of peptides, and yet retain a significant OTR agonist activity. The results of this study also expose the potential challenge of using the N-methylation strategy for the OT system; while exposed polarity is reduced, in some cases backbone methylation produces a significant conformational change that compromises agonist activity. The data presented provides useful insights on the SAR of OT and suggests future design strategies that can be used to develop more permeable OTR agonists based on the OT framework. (C) 2016 Published by Elsevier Ltd.
Author Sciabola, Simone
Rogers, Bruce N.
Fonseca, Kari R.
Duplantier, Allen
Kablaoui, Natasha M.
Gray, David L.
Goetz, Gilles H.
Bai, Guoyun
Vanase-Frawley, Michelle A.
Author_xml – sequence: 1
  givenname: Simone
  surname: Sciabola
  fullname: Sciabola, Simone
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA
– sequence: 2
  givenname: Gilles H.
  surname: Goetz
  fullname: Goetz, Gilles H.
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA
– sequence: 3
  givenname: Guoyun
  surname: Bai
  fullname: Bai, Guoyun
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA
– sequence: 4
  givenname: Bruce N.
  surname: Rogers
  fullname: Rogers, Bruce N.
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA
– sequence: 5
  givenname: David L.
  surname: Gray
  fullname: Gray, David L.
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA
– sequence: 6
  givenname: Allen
  surname: Duplantier
  fullname: Duplantier, Allen
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA
– sequence: 7
  givenname: Kari R.
  surname: Fonseca
  fullname: Fonseca, Kari R.
  organization: Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Cambridge, MA 02139, USA
– sequence: 8
  givenname: Michelle A.
  surname: Vanase-Frawley
  fullname: Vanase-Frawley, Michelle A.
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA
– sequence: 9
  givenname: Natasha M.
  surname: Kablaoui
  fullname: Kablaoui, Natasha M.
  email: Natasha.M.Kablaoui@pfizer.com
  organization: Worldwide Medicinal Chemistry, Pfizer Global Research & Development, Neuroscience, 610 Main Street, Cambridge, MA 02139, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27297999$$D View this record in MEDLINE/PubMed
BookMark eNqNkUuP0zAURi00iOkM_AA2yEsklHKdhxPDalTxGGkEC2BtOfZN65LYxXYY8u9xaZklYuPH1fmu7HOvyIXzDgl5zmDNgPHX-3U_6XWZj2to1sDLR2TFal4XVSXYBVmB4F0BneCX5CrGPQCUtWBPyGXZlqIVQqzI7ssSE04qWU0_FROm3TLmi3fUD9T_WpLX1r2ht9NB6URz-bBTYVLaj367UOUMtS4FNfkR9TyqQHeLCX6LjvbeGeu21GG69-H7U_J4UGPEZ-f9mnx7_-7r5mNx9_nD7ebmrtA1E6kYeigV9By1FspwOC5GDVVj6r6GthuYUJ1ucqEWujJmUNCxpuTQdZkpdXVNXp76HoL_MWNMcrJR4zgqh36OknXQtJyLlmeUnVAdfIwBB3kIdlJhkQzkUbDcyyxYHgVLaGQWnDMvzu3nfkLzkPhrNAOvTsA99n6I2qLT-IDlEVT5Aaxpj8OATHf_T29s-jOajZ9dytG3pyhmmz8tBnmOGxtQJ2m8_cc_fgM5ZLBa
CitedBy_id crossref_primary_10_1021_acsmedchemlett_2c00455
crossref_primary_10_1016_j_scitotenv_2021_148034
crossref_primary_10_1038_s41467_018_07616_w
crossref_primary_10_3390_ijms222112077
crossref_primary_10_1002_med_21562
crossref_primary_10_1021_acsmedchemlett_0c00581
crossref_primary_10_1021_acs_jmedchem_7b01028
crossref_primary_10_1016_j_drudis_2020_01_012
crossref_primary_10_1021_acs_jafc_3c00877
crossref_primary_10_1002_chem_202300753
crossref_primary_10_1021_acs_jmedchem_2c00094
crossref_primary_10_1002_prp2_290
crossref_primary_10_1016_j_jbc_2022_101656
crossref_primary_10_1021_acs_jmedchem_8b01691
crossref_primary_10_1021_acs_jmedchem_9b01862
crossref_primary_10_1080_26395940_2023_2242701
crossref_primary_10_1016_j_bmcl_2017_12_027
crossref_primary_10_1016_j_biopha_2020_109832
crossref_primary_10_1021_acs_jmedchem_3c02332
crossref_primary_10_1039_C7MD00101K
Cites_doi 10.1016/j.psyneuen.2009.06.016
10.1021/ml500239m
10.1016/j.neuron.2008.04.009
10.1016/j.psyneuen.2009.04.002
10.1517/17425247.2011.633508
10.1002/bdd.750
10.1021/jm401859b
10.1002/mrc.2557
10.1038/sj.npp.1300021
10.1371/journal.pone.0001128
10.1126/science.1189047
10.1021/acs.jmedchem.5b00128
10.1039/c1md00093d
10.1021/ar8000603
10.1021/jm049205z
10.1021/ja303200d
10.1016/j.biopsych.2010.04.039
10.1021/cb300515u
10.1111/cbdd.12055
10.1002/jps.20125
10.1517/17425247.2011.588204
10.1002/anie.200705797
10.1002/prot.20033
10.1016/j.biopsych.2006.05.030
10.1016/j.yfrne.2011.07.001
10.1021/mp1003306
10.1016/0165-1781(93)90035-F
10.1046/j.1365-4362.36.s1.2.x
10.1021/ja00724a016
10.2174/0929866053765752
10.1021/bi00240a030
10.1016/S0021-9258(19)83740-7
10.1073/pnas.66.1.111
10.1126/science.3008332
10.1002/hlca.19850680319
10.1016/S0021-9258(18)64530-2
10.1016/0898-5529(90)90156-3
10.1007/BF00198370
10.2165/00063030-200519030-00003
10.1002/bip.360321203
10.1073/pnas.68.5.956
10.1021/bi00614a014
ContentType Journal Article
Copyright 2016
Copyright © 2016. Published by Elsevier Ltd.
Copyright_xml – notice: 2016
– notice: Copyright © 2016. Published by Elsevier Ltd.
DBID 1KM
BLEPL
DTL
GYFQL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.bmc.2016.05.062
DatabaseName Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 2016
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Web of Science
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3391
EndPage 3520
ExternalDocumentID 10_1016_j_bmc_2016_05_062
27297999
000380515700020
S0968089616304060
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPC
SPCBC
SSH
SSK
SSP
SSU
SSZ
T5K
UPT
XPP
YK3
~02
~G-
1KM
AAXKI
AKRWK
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
CGR
CUY
CVF
ECM
EIF
NPM
53G
AAQXK
AAYXX
ABXDB
ACNNM
ACRPL
ADMUD
ADNMO
AFFNX
AFJKZ
AGHFR
AGRDE
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
G-2
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
R2-
SAE
SCB
SEW
SOC
SPT
WUQ
ZMT
7X8
ID FETCH-LOGICAL-c419t-fb02a0b6ecc9ad609ad6daf35d4b4078f19a8c5f3549c3ddfa08152608835d2c3
IEDL.DBID AIKHN
ISICitedReferencesCount 24
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000380515700020
ISSN 0968-0896
IngestDate Sat Oct 26 01:14:22 EDT 2024
Fri Dec 06 01:19:00 EST 2024
Sat Sep 28 08:50:38 EDT 2024
Fri Dec 13 17:54:09 EST 2024
Tue Sep 17 23:02:33 EDT 2024
Fri Feb 23 02:30:58 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 16
Keywords Hidden polarity
SFC
NMR
Cyclic peptide
Oxytocin
SPPS
Polarity
FLIPR
Intramolecular hydrogen bond
Hydrogen bonding
Peptide
Mpa
PERMEABILITY
HUMANS
INTRANASAL DELIVERY
CONFORMATION
CYCLIC-PEPTIDES
HIGHLY POTENT ANALOGUE
PEPTIDE-HORMONE-OXYTOCIN
ORAL BIOAVAILABILITY
DIMETHYL-SULFOXIDE
Language English
License Copyright © 2016. Published by Elsevier Ltd.
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c419t-fb02a0b6ecc9ad609ad6daf35d4b4078f19a8c5f3549c3ddfa08152608835d2c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5316-1586
0000-0001-6524-9278
PMID 27297999
PQID 1805766976
PQPubID 23479
PageCount 8
ParticipantIDs webofscience_primary_000380515700020
webofscience_primary_000380515700020CitationCount
proquest_miscellaneous_1805766976
crossref_primary_10_1016_j_bmc_2016_05_062
elsevier_sciencedirect_doi_10_1016_j_bmc_2016_05_062
pubmed_primary_27297999
PublicationCentury 2000
PublicationDate 2016-08-15
PublicationDateYYYYMMDD 2016-08-15
PublicationDate_xml – month: 08
  year: 2016
  text: 2016-08-15
  day: 15
PublicationDecade 2010
PublicationPlace OXFORD
PublicationPlace_xml – name: OXFORD
– name: England
PublicationTitle Bioorganic & medicinal chemistry
PublicationTitleAbbrev BIOORGAN MED CHEM
PublicationTitleAlternate Bioorg Med Chem
PublicationYear 2016
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References du Vigneaud, Winestock, Murti, Hope, Kimbrough, Hope, Murti, du Vigneaud, Manning, Stoev, Chini, Durroux, Mouillac, Guillon (b0095) 1960; 235
Striepens, Kendrick, Maier, Hurlemann (b0005) 2011; 32
Choc (b0070) 1997; 36
Budesinsky, Prochazka, Slaninova, Wittelsberger, Patiny, Slaninova, Barberis, Mutter (b0100) 2005; 12
Pitman, Orr, Lasko (b0035) 1993; 48
Deber, Bovey, Carver, Blout (b0105) 1970; 92
Gasteiger, Rudolph, Sadowski (b0110) 1990; 3
Goetz, Philippe, Shapiro, Goetz, Farrell, Shalaeva, Sciabola, Anderson, Yan, Philippe, Shapiro (b0065) 2014; 5
Hamman, Enslin, Kotze, Fasinu, Pillay, Ndesendo, du Toit, Choonara (b0055) 2005; 19
Feifel, Macdonald, Nguyen, Cobb, Warlan, Galangue, Minassian, Becker, Cooper, Perry, Lefebvre, Gonzales, Hadley (b0030) 2010; 68
Baumgartner, Heinrichs, Vonlanthen, Fischbacher, Fehr (b0015) 2008; 58
Craik, Fairlie, Liras, Price, Bock, Gavenonis, Kritzer, Beck, Chatterjee, Laufer, Kiran, Frank, Neubauer, Ovadia, Greenberg, Gilon, Hoffman, Kessler, Ovadia, Greenberg, Chatterjee, Laufer, Opperer, Kessler, Gilon, Hoffman (b0075) 2013; 81
Biron, Chatterjee, Ovadia, Langenegger, Brueggen, Hoyer, Schmid, Jelinek, Gilon, Hoffman, Kessler, Chatterjee, Gilon, Hoffman, Kessler (b0085) 2008; 47
De Dreu, Greer, Handgraaf, Shalvi, Van Kleef, Baas, Ten Velden, Van Dijk, Feith, Zak, Stanton, Ahmadi (b0020) 2010; 328
Tang, Persky, Hochhaus, Meibohm (b0050) 2004; 93
Onufriev, Bashford, Case (b0115) 2004; 55
Hollander, Novotny, Hanratty, Yaffe, DeCaria, Aronowitz, Mosovich, Hollander, Bartz, Chaplin, Phillips, Sumner, Soorya, Anagnostou, Wasserman (b0040) 2003; 28
Fesik, Gampe, Eaton, Gemmecker, Olejniczak, Neri, Holzman, Egan, Edalji, Loosli, Kesslerb, Oschkinatb, Weber, Petchera, Widmera (b0060) 1991; 30
Wood, Tickle, Treharne, Pitts, Mascarenhas, Li, Husain, Cooper, Blundell, Hruby, Urry, Ohnishi, Walter, Ohno, Kawasaki, Fukuhara, Okuda, Yamaguchi, Bhaskaran, Chuang, Yu, Ballardin, Fischman, Gibbons, Roy, Schwartz, Smith, Walter, Wyssbrod, Kato, Endo, Fujiwara, Nagayama, Urry, Walter (b0090) 1986; 232
Buchheim, Heinrichs, George, Pokorny, Koops, Henningsen, O’Connor, Gundel (b0010) 2009; 34
Domes, Lischke, Berger, Grossmann, Hauenstein, Heinrichs, Herpertz (b0025) 2010; 35
Liu, Malerba, Paoletti, Capsoni, Cattaneo (b0045) 2011; 8
Alex, Millan, Perez, Wakenhut, Whitlock, Bockus, Lexa, Pye, Kalgutkar, Gardner, Hund, Hewitt, Schwochert, Glassey, Price, Mathiowetz, Liras, Jacobson, Lokey (b0080) 2011; 2
Hollander, E (WOS:000180796400022) 2003; 28
BHASKARAN, R (WOS:A1992JZ64900002) 1992; 32
Domes, G (WOS:000273844100009) 2010; 35
Beck, JG (WOS:000306724500060) 2012; 134
Ovadia, O (WOS:000289008600017) 2011; 8
Gasteiger, J. (000380515700020.21) 1990; 3
Fasinu, P (WOS:000290491100001) 2011; 32
Onufriev, A (WOS:000220980600016) 2004; 55
Buchheim, A (WOS:000270777500016) 2009; 34
DEBER, CM (WOS:A1970H557400016) 1970; 92
Hamman, JH (WOS:000230829000003) 2005; 19
Bock, JE (WOS:000316375500002) 2013; 8
Malerba, F (WOS:000295330300004) 2011; 8
Manning, M. (000380515700020.31) 1000
Wittelsberger, A (WOS:000232781600004) 2005; 48
De Dreu, CKW (WOS:000278598400042) 2010; 328
Choc, MG (WOS:000071617200001) 1997; 36
URRY, DW (WOS:A1971J330200021) 1971; 68
Tang, L (WOS:000223561900002) 2004; 93
Liu, XF (WOS:000297224500010) 2011; 8
WOOD, SP (WOS:A1986C034500027) 1986; 232
Craik, DJ (WOS:000312546000015) 2013; 81
Hollander, E (WOS:000244344400011) 2007; 61
HOPE, DB (WOS:A19623975B00020) 1962; 237
Baumgartner, T (WOS:000256120500016) 2008; 58
PITMAN, RK (WOS:A1993LX20700002) 1993; 48
Goetz, GH (WOS:000334572000011) 2014; 57
Alex, A (WOS:000293316800018) 2011; 2
Chatterjee, J (WOS:000260254300011) 2008; 41
Feifel, D (WOS:000282356900015) 2010; 68
KATO, T (WOS:A1993MK83000004) 1993; 3
DUVIGNEAUD, V (WOS:A1960WA43300062) 1960; 235
Zak, PJ (WOS:000207459000012) 2007; 2
Ohno, A (WOS:000273900400013) 2010; 48
Biron, E (WOS:000254869800009) 2008; 47
Bockus, AT (WOS:000356316600013) 2015; 58
FESIK, SW (WOS:A1991FU89800030) 1991; 30
BALLARDIN, A (WOS:A1978FT40200014) 1978; 17
URRY, DW (WOS:A1970G471700018) 1970; 66
LOOSLI, HR (WOS:A1985AHM9600018) 1985; 68
Striepens, N (WOS:000295556000005) 2011; 32
Goetz, GH (WOS:000343016700020) 2014; 5
Budesinsky, M (WOS:000229162900008) 2005; 12
Goetz (10.1016/j.bmc.2016.05.062_h0095) 2014; 57
Beck (10.1016/j.bmc.2016.05.062_h0115) 2012; 134
Ovadia (10.1016/j.bmc.2016.05.062_h0120) 2011; 8
Gasteiger (10.1016/j.bmc.2016.05.062_b0110) 1990; 3
Zak (10.1016/j.bmc.2016.05.062_h0025) 2007; 2
Fasinu (10.1016/j.bmc.2016.05.062_h0075) 2011; 32
Hollander (10.1016/j.bmc.2016.05.062_h0050) 2007; 61
Hamman (10.1016/j.bmc.2016.05.062_h0070) 2005; 19
Wood (10.1016/j.bmc.2016.05.062_h0145) 1986; 232
Urry (10.1016/j.bmc.2016.05.062_h0175) 1971; 68
Budesinsky (10.1016/j.bmc.2016.05.062_h0195) 2005; 12
Deber (10.1016/j.bmc.2016.05.062_b0105) 1970; 92
Urry (10.1016/j.bmc.2016.05.062_h0150) 1970; 66
Wittelsberger (10.1016/j.bmc.2016.05.062_h0200) 2005; 48
Choc (10.1016/j.bmc.2016.05.062_b0070) 1997; 36
Tang (10.1016/j.bmc.2016.05.062_b0050) 2004; 93
Feifel (10.1016/j.bmc.2016.05.062_b0030) 2010; 68
Fesik (10.1016/j.bmc.2016.05.062_h0080) 1991; 30
Biron (10.1016/j.bmc.2016.05.062_h0135) 2008; 47
Pitman (10.1016/j.bmc.2016.05.062_b0035) 1993; 48
Bhaskaran (10.1016/j.bmc.2016.05.062_h0160) 1992; 32
Onufriev (10.1016/j.bmc.2016.05.062_b0115) 2004; 55
Liu (10.1016/j.bmc.2016.05.062_h0055) 2011; 8
Ballardin (10.1016/j.bmc.2016.05.062_h0165) 1978; 17
du Vigneaud (10.1016/j.bmc.2016.05.062_h0180) 1960; 235
Ohno (10.1016/j.bmc.2016.05.062_h0155) 2010; 48
Bockus (10.1016/j.bmc.2016.05.062_h0130) 2015; 58
Striepens (10.1016/j.bmc.2016.05.062_b0005) 2011; 32
Hollander (10.1016/j.bmc.2016.05.062_h0045) 2003; 28
Manning (10.1016/j.bmc.2016.05.062_h0190) 2008; Vol. 170
Buchheim (10.1016/j.bmc.2016.05.062_b0010) 2009; 34
Craik (10.1016/j.bmc.2016.05.062_h0105) 2013; 81
Hope (10.1016/j.bmc.2016.05.062_h0185) 1962; 237
Chatterjee (10.1016/j.bmc.2016.05.062_h0140) 2008; 41
Kato (10.1016/j.bmc.2016.05.062_h0170) 1993; 3
Domes (10.1016/j.bmc.2016.05.062_b0025) 2010; 35
Malerba (10.1016/j.bmc.2016.05.062_h0060) 2011; 8
Goetz (10.1016/j.bmc.2016.05.062_h0090) 2014; 5
De Dreu (10.1016/j.bmc.2016.05.062_h0020) 2010; 328
Loosli (10.1016/j.bmc.2016.05.062_h0085) 1985; 68
Bock (10.1016/j.bmc.2016.05.062_h0110) 2012; 8
Baumgartner (10.1016/j.bmc.2016.05.062_b0015) 2008; 58
Alex (10.1016/j.bmc.2016.05.062_h0125) 2011; 2
References_xml – volume: 68
  start-page: 678
  year: 2010
  ident: b0030
  publication-title: Biol. Psychiatry
  contributor:
    fullname: Hadley
– volume: 35
  start-page: 83
  year: 2010
  ident: b0025
  publication-title: Psychoneuroendocrinology
  contributor:
    fullname: Herpertz
– volume: 48
  start-page: 107
  year: 1993
  ident: b0035
  publication-title: Psychiatry Res.
  contributor:
    fullname: Lasko
– volume: 55
  start-page: 383
  year: 2004
  ident: b0115
  publication-title: Proteins
  contributor:
    fullname: Case
– volume: 58
  start-page: 639
  year: 2008
  ident: b0015
  publication-title: Neuron
  contributor:
    fullname: Fehr
– volume: 2
  start-page: 669
  year: 2011
  ident: b0080
  publication-title: MedChemComm
  contributor:
    fullname: Lokey
– volume: 47
  start-page: 2595
  year: 2008
  ident: b0085
  publication-title: Angew. Chem., Int. Ed.
  contributor:
    fullname: Kessler
– volume: 93
  start-page: 2184
  year: 2004
  ident: b0050
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Meibohm
– volume: 3
  start-page: 537
  year: 1990
  ident: b0110
  publication-title: Tetrahedron Comput. Methodol.
  contributor:
    fullname: Sadowski
– volume: 19
  start-page: 165
  year: 2005
  ident: b0055
  publication-title: BioDrugs
  contributor:
    fullname: Choonara
– volume: 5
  start-page: 1167
  year: 2014
  ident: b0065
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Shapiro
– volume: 34
  start-page: 1417
  year: 2009
  ident: b0010
  publication-title: Psychoneuroendocrinology
  contributor:
    fullname: Gundel
– volume: 81
  start-page: 136
  year: 2013
  ident: b0075
  publication-title: Chem. Biol. Drug Des.
  contributor:
    fullname: Hoffman
– volume: 235
  start-page: PC64
  year: 1960
  end-page: 512
  ident: b0095
  article-title: Peptide and Non-Peptide Agonists and Antagonists for the Vasopressin and Oxytocin V1a, V1b, V2 and OT Receptors: Research Tools and Potential Therapeutic Agents
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Guillon
– volume: 8
  start-page: 1681
  year: 2011
  ident: b0045
  publication-title: Expert Opin. Drug Deliv.
  contributor:
    fullname: Cattaneo
– volume: 30
  start-page: 6574
  year: 1991
  ident: b0060
  publication-title: Biochemistry
  contributor:
    fullname: Widmera
– volume: 92
  start-page: 6191
  year: 1970
  ident: b0105
  publication-title: J. Am. Chem. Soc.
  contributor:
    fullname: Blout
– volume: 32
  start-page: 426
  year: 2011
  ident: b0005
  publication-title: Front. Neuroendocrinol.
  contributor:
    fullname: Hurlemann
– volume: 328
  start-page: 1408
  year: 2010
  ident: b0020
  publication-title: Science
  contributor:
    fullname: Ahmadi
– volume: 28
  start-page: 193
  year: 2003
  ident: b0040
  publication-title: Neuropsychopharmacology
  contributor:
    fullname: Wasserman
– volume: 232
  start-page: 633
  year: 1986
  ident: b0090
  publication-title: Science
  contributor:
    fullname: Walter
– volume: 12
  start-page: 343
  year: 2005
  ident: b0100
  publication-title: Protein Pept. Lett.
  contributor:
    fullname: Mutter
– volume: 36
  start-page: 1
  year: 1997
  ident: b0070
  publication-title: Int. J. Dermatol.
  contributor:
    fullname: Choc
– volume: 35
  start-page: 83
  year: 2010
  ident: WOS:000273844100009
  article-title: Effects of intranasal oxytocin on emotional face processing in women
  publication-title: PSYCHONEUROENDOCRINOLOGY
  doi: 10.1016/j.psyneuen.2009.06.016
  contributor:
    fullname: Domes, G
– volume: 5
  start-page: 1167
  year: 2014
  ident: WOS:000343016700020
  article-title: EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides
  publication-title: ACS MEDICINAL CHEMISTRY LETTERS
  doi: 10.1021/ml500239m
  contributor:
    fullname: Goetz, GH
– volume: 58
  start-page: 639
  year: 2008
  ident: WOS:000256120500016
  article-title: Oxytocin shapes the neural circuitry of trust and trust adaptation in humans
  publication-title: NEURON
  doi: 10.1016/j.neuron.2008.04.009
  contributor:
    fullname: Baumgartner, T
– volume: 235
  start-page: PC64
  year: 1960
  ident: WOS:A1960WA43300062
  article-title: SYNTHESIS OF 1-BETA-MERCAPTOPROPIONIC ACID OXYTOCIN (DESAMINO-OXYTOCIN), A HIGHLY POTENT ANALOGUE OF OXYTOCIN
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  contributor:
    fullname: DUVIGNEAUD, V
– volume: 34
  start-page: 1417
  year: 2009
  ident: WOS:000270777500016
  article-title: Oxytocin enhances the experience of attachment security
  publication-title: PSYCHONEUROENDOCRINOLOGY
  doi: 10.1016/j.psyneuen.2009.04.002
  contributor:
    fullname: Buchheim, A
– volume: 3
  start-page: 537
  year: 1990
  ident: 000380515700020.21
  article-title: Automatic Generation of 3D-Atomic Coordinates for Organic Molecules
  publication-title: Tetrahedron Comput. Methodol.
  contributor:
    fullname: Gasteiger, J.
– volume: 3
  start-page: 653
  year: 1993
  ident: WOS:A1993MK83000004
  article-title: OXYTOCIN SOLUTION STRUCTURE CHANGES UPON PROTONATION OF THE N-TERMINUS IN DIMETHYL-SULFOXIDE
  publication-title: JOURNAL OF BIOMOLECULAR NMR
  contributor:
    fullname: KATO, T
– volume: 237
  start-page: 1563
  year: 1962
  ident: WOS:A19623975B00020
  article-title: HIGHLY POTENT ANALOGUE OF OXYTOCIN, DESAMINO-OXYTOCINO-OXYTOCIN
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  contributor:
    fullname: HOPE, DB
– volume: 8
  start-page: 1681
  year: 2011
  ident: WOS:000297224500010
  article-title: Clinical trials of intranasal delivery for treating neurological disorders - a critical review
  publication-title: EXPERT OPINION ON DRUG DELIVERY
  doi: 10.1517/17425247.2011.633508
  contributor:
    fullname: Liu, XF
– volume: 32
  start-page: 185
  year: 2011
  ident: WOS:000290491100001
  article-title: Diverse approaches for the enhancement of oral drug bioavailability
  publication-title: BIOPHARMACEUTICS & DRUG DISPOSITION
  doi: 10.1002/bdd.750
  contributor:
    fullname: Fasinu, P
– volume: 17
  start-page: 4443
  year: 1978
  ident: WOS:A1978FT40200014
  article-title: CONFORMATIONAL STUDIES ON [PRO3,GLY4]-OXYTOCIN IN DIMETHYL-SULFOXIDE BY H-1 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY - EVIDENCE FOR A TYPE-II BETA-TURN IN CYCLIC MOIETY
  publication-title: BIOCHEMISTRY
  contributor:
    fullname: BALLARDIN, A
– volume: 48
  start-page: 107
  year: 1993
  ident: WOS:A1993LX20700002
  article-title: EFFECTS OF INTRANASAL VASOPRESSIN AND OXYTOCIN ON PHYSIOLOGICAL RESPONDING DURING PERSONAL COMBAT IMAGERY IN VIETNAM VETERANS WITH POSTTRAUMATIC-STRESS-DISORDER
  publication-title: PSYCHIATRY RESEARCH
  contributor:
    fullname: PITMAN, RK
– volume: 57
  start-page: 2920
  year: 2014
  ident: WOS:000334572000011
  article-title: High Throughput Method for the Indirect Detection of Intramolecular Hydrogen Bonding
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm401859b
  contributor:
    fullname: Goetz, GH
– volume: 68
  start-page: 956
  year: 1971
  ident: WOS:A1971J330200021
  article-title: PROPOSED CONFORMATION OF OXYTOCIN IN SOLUTION
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  contributor:
    fullname: URRY, DW
– volume: 48
  start-page: 168
  year: 2010
  ident: WOS:000273900400013
  article-title: Complete NMR analysis of oxytocin in phosphate buffer
  publication-title: MAGNETIC RESONANCE IN CHEMISTRY
  doi: 10.1002/mrc.2557
  contributor:
    fullname: Ohno, A
– volume: 19
  start-page: 165
  year: 2005
  ident: WOS:000230829000003
  article-title: Oral delivery of peptide drugs - Barriers and developments
  publication-title: BIODRUGS
  contributor:
    fullname: Hamman, JH
– volume: 36
  start-page: 1
  year: 1997
  ident: WOS:000071617200001
  article-title: Bioavailability and pharmacokinetics of cyclosporine formulations: Neoral (R) vs Sandimmune (R)
  publication-title: INTERNATIONAL JOURNAL OF DERMATOLOGY
  contributor:
    fullname: Choc, MG
– volume: 68
  start-page: 682
  year: 1985
  ident: WOS:A1985AHM9600018
  article-title: PEPTIDE CONFORMATIONS .31. THE CONFORMATION OF CYCLOSPORIN-A IN THE CRYSTAL AND IN SOLUTION
  publication-title: HELVETICA CHIMICA ACTA
  contributor:
    fullname: LOOSLI, HR
– volume: 28
  start-page: 193
  year: 2003
  ident: WOS:000180796400022
  article-title: Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders
  publication-title: NEUROPSYCHOPHARMACOLOGY
  doi: 10.1038/sj.npp.1300021
  contributor:
    fullname: Hollander, E
– volume: 2
  start-page: ARTN e1128
  year: 2007
  ident: WOS:000207459000012
  article-title: Oxytocin Increases Generosity in Humans
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0001128
  contributor:
    fullname: Zak, PJ
– volume: 328
  start-page: 1408
  year: 2010
  ident: WOS:000278598400042
  article-title: The Neuropeptide Oxytocin Regulates Parochial Altruism in Intergroup Conflict Among Humans
  publication-title: SCIENCE
  doi: 10.1126/science.1189047
  contributor:
    fullname: De Dreu, CKW
– volume: 58
  start-page: 4581
  year: 2015
  ident: WOS:000356316600013
  article-title: Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/acs.jmedchem.5b00128
  contributor:
    fullname: Bockus, AT
– volume: 30
  start-page: 6574
  year: 1991
  ident: WOS:A1991FU89800030
  article-title: NMR-STUDIES OF [U-C-13]CYCLOSPORIN-A BOUND TO CYCLOPHILIN - BOUND CONFORMATION AND PORTIONS OF CYCLOSPORINE INVOLVED IN BINDING
  publication-title: BIOCHEMISTRY
  contributor:
    fullname: FESIK, SW
– volume: 66
  start-page: 111
  year: 1970
  ident: WOS:A1970G471700018
  article-title: SECONDARY STRUCTURE OF CYCLIC MOIETY OF PEPTIDE HORMONE OXYTOCIN AND ITS DEAMINO ANALOG
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  contributor:
    fullname: URRY, DW
– volume: 32
  start-page: 1599
  year: 1992
  ident: WOS:A1992JZ64900002
  article-title: CONFORMATIONAL PROPERTIES OF OXYTOCIN IN DIMETHYL-SULFOXIDE SOLUTION - NMR AND RESTRAINED MOLECULAR-DYNAMICS STUDIES
  publication-title: BIOPOLYMERS
  contributor:
    fullname: BHASKARAN, R
– volume: 12
  start-page: 343
  year: 2005
  ident: WOS:000229162900008
  article-title: Oxytocin and its analogs, methyl-substituted in ortho-, meta- or para-position of aromatic ring of phenylalanine in position 2: NMR study and biological activities
  publication-title: PROTEIN AND PEPTIDE LETTERS
  contributor:
    fullname: Budesinsky, M
– volume: 2
  start-page: 669
  year: 2011
  ident: WOS:000293316800018
  article-title: Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space
  publication-title: MEDCHEMCOMM
  doi: 10.1039/c1md00093d
  contributor:
    fullname: Alex, A
– volume: 41
  start-page: 1331
  year: 2008
  ident: WOS:000260254300011
  article-title: N-Methylation of Peptides: A New Perspective in Medicinal Chemistry
  publication-title: ACCOUNTS OF CHEMICAL RESEARCH
  doi: 10.1021/ar8000603
  contributor:
    fullname: Chatterjee, J
– volume: 48
  start-page: 6553
  year: 2005
  ident: WOS:000232781600004
  article-title: Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm049205z
  contributor:
    fullname: Wittelsberger, A
– volume: 134
  start-page: 12125
  year: 2012
  ident: WOS:000306724500060
  article-title: Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja303200d
  contributor:
    fullname: Beck, JG
– volume: 68
  start-page: 678
  year: 2010
  ident: WOS:000282356900015
  article-title: Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients
  publication-title: BIOLOGICAL PSYCHIATRY
  doi: 10.1016/j.biopsych.2010.04.039
  contributor:
    fullname: Feifel, D
– volume: 8
  start-page: 488
  year: 2013
  ident: WOS:000316375500002
  article-title: Getting in Shape: Controlling Peptide Bioactivity and Bioavailability Using Conformational Constraints
  publication-title: ACS CHEMICAL BIOLOGY
  doi: 10.1021/cb300515u
  contributor:
    fullname: Bock, JE
– volume: 92
  start-page: 6191
  year: 1970
  ident: WOS:A1970H557400016
  article-title: NUCLEAR MAGNETIC RESONANCE EVIDENCE FOR CIS-PEPTIDE BONDS IN PROLINE OLIGOMERS
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  contributor:
    fullname: DEBER, CM
– volume: 81
  start-page: 136
  year: 2013
  ident: WOS:000312546000015
  article-title: The Future of Peptide-based Drugs
  publication-title: CHEMICAL BIOLOGY & DRUG DESIGN
  doi: 10.1111/cbdd.12055
  contributor:
    fullname: Craik, DJ
– volume: 93
  start-page: 2184
  year: 2004
  ident: WOS:000223561900002
  article-title: Pharmacokinetic aspects of biotechnology products
  publication-title: JOURNAL OF PHARMACEUTICAL SCIENCES
  doi: 10.1002/jps.20125
  contributor:
    fullname: Tang, L
– volume: 8
  start-page: 1277
  year: 2011
  ident: WOS:000295330300004
  article-title: Intranasal delivery of therapeutic proteins for neurological diseases
  publication-title: EXPERT OPINION ON DRUG DELIVERY
  doi: 10.1517/17425247.2011.588204
  contributor:
    fullname: Malerba, F
– volume: 47
  start-page: 2595
  year: 2008
  ident: WOS:000254869800009
  article-title: Improving oral bioavailability of peptides by multiple N-methylation: Somatostatin analogues
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  doi: 10.1002/anie.200705797
  contributor:
    fullname: Biron, E
– volume: 55
  start-page: 383
  year: 2004
  ident: WOS:000220980600016
  article-title: Exploring protein native states and large-scale conformational changes with a modified generalized born model
  publication-title: PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
  doi: 10.1002/prot.20033
  contributor:
    fullname: Onufriev, A
– year: 1000
  ident: 000380515700020.31
  article-title: Peptide and Non-Peptide Agonists and Antagonists for the Vasopressin and Oxytocin V1a, V1b, V2 and OT Receptors: Research Tools and Potential Therapeutic Agents
  publication-title: Progress in Brain Research
  contributor:
    fullname: Manning, M.
– volume: 232
  start-page: 633
  year: 1986
  ident: WOS:A1986C034500027
  article-title: CRYSTAL-STRUCTURE ANALYSIS OF DEAMINO-OXYTOCIN - CONFORMATIONAL FLEXIBILITY AND RECEPTOR-BINDING
  publication-title: SCIENCE
  contributor:
    fullname: WOOD, SP
– volume: 61
  start-page: 498
  year: 2007
  ident: WOS:000244344400011
  article-title: Oxytocin increases retention of social cognition in autism
  publication-title: BIOLOGICAL PSYCHIATRY
  doi: 10.1016/j.biopsych.2006.05.030
  contributor:
    fullname: Hollander, E
– volume: 32
  start-page: 426
  year: 2011
  ident: WOS:000295556000005
  article-title: Prosocial effects of oxytocin and clinical evidence for its therapeutic potential
  publication-title: FRONTIERS IN NEUROENDOCRINOLOGY
  doi: 10.1016/j.yfrne.2011.07.001
  contributor:
    fullname: Striepens, N
– volume: 8
  start-page: 479
  year: 2011
  ident: WOS:000289008600017
  article-title: The Effect of Multiple N-Methylation on Intestinal Permeability of Cyclic Hexapeptides
  publication-title: MOLECULAR PHARMACEUTICS
  doi: 10.1021/mp1003306
  contributor:
    fullname: Ovadia, O
– volume: 8
  start-page: 488
  year: 2012
  ident: 10.1016/j.bmc.2016.05.062_h0110
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb300515u
  contributor:
    fullname: Bock
– volume: 328
  start-page: 1408
  year: 2010
  ident: 10.1016/j.bmc.2016.05.062_h0020
  publication-title: Science
  doi: 10.1126/science.1189047
  contributor:
    fullname: De Dreu
– volume: 48
  start-page: 107
  year: 1993
  ident: 10.1016/j.bmc.2016.05.062_b0035
  publication-title: Psychiatry Res.
  doi: 10.1016/0165-1781(93)90035-F
  contributor:
    fullname: Pitman
– volume: 36
  start-page: 1
  year: 1997
  ident: 10.1016/j.bmc.2016.05.062_b0070
  publication-title: Int. J. Dermatol.
  doi: 10.1046/j.1365-4362.36.s1.2.x
  contributor:
    fullname: Choc
– volume: 92
  start-page: 6191
  year: 1970
  ident: 10.1016/j.bmc.2016.05.062_b0105
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja00724a016
  contributor:
    fullname: Deber
– volume: 12
  start-page: 343
  year: 2005
  ident: 10.1016/j.bmc.2016.05.062_h0195
  publication-title: Protein Pept. Lett.
  doi: 10.2174/0929866053765752
  contributor:
    fullname: Budesinsky
– volume: 8
  start-page: 1277
  year: 2011
  ident: 10.1016/j.bmc.2016.05.062_h0060
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2011.588204
  contributor:
    fullname: Malerba
– volume: 30
  start-page: 6574
  year: 1991
  ident: 10.1016/j.bmc.2016.05.062_h0080
  publication-title: Biochemistry
  doi: 10.1021/bi00240a030
  contributor:
    fullname: Fesik
– volume: 68
  start-page: 678
  year: 2010
  ident: 10.1016/j.bmc.2016.05.062_b0030
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2010.04.039
  contributor:
    fullname: Feifel
– volume: 8
  start-page: 1681
  year: 2011
  ident: 10.1016/j.bmc.2016.05.062_h0055
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2011.633508
  contributor:
    fullname: Liu
– volume: 32
  start-page: 185
  year: 2011
  ident: 10.1016/j.bmc.2016.05.062_h0075
  publication-title: Biopharm. Drug Dispos.
  doi: 10.1002/bdd.750
  contributor:
    fullname: Fasinu
– volume: 237
  start-page: 1563
  year: 1962
  ident: 10.1016/j.bmc.2016.05.062_h0185
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)83740-7
  contributor:
    fullname: Hope
– volume: 34
  start-page: 1417
  year: 2009
  ident: 10.1016/j.bmc.2016.05.062_b0010
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2009.04.002
  contributor:
    fullname: Buchheim
– volume: 61
  start-page: 498
  year: 2007
  ident: 10.1016/j.bmc.2016.05.062_h0050
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2006.05.030
  contributor:
    fullname: Hollander
– volume: 66
  start-page: 111
  year: 1970
  ident: 10.1016/j.bmc.2016.05.062_h0150
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.66.1.111
  contributor:
    fullname: Urry
– volume: 232
  start-page: 633
  year: 1986
  ident: 10.1016/j.bmc.2016.05.062_h0145
  publication-title: Science
  doi: 10.1126/science.3008332
  contributor:
    fullname: Wood
– volume: 81
  start-page: 136
  year: 2013
  ident: 10.1016/j.bmc.2016.05.062_h0105
  publication-title: Chem. Biol. Drug Des.
  doi: 10.1111/cbdd.12055
  contributor:
    fullname: Craik
– volume: 41
  start-page: 1331
  year: 2008
  ident: 10.1016/j.bmc.2016.05.062_h0140
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar8000603
  contributor:
    fullname: Chatterjee
– volume: 68
  start-page: 682
  year: 1985
  ident: 10.1016/j.bmc.2016.05.062_h0085
  publication-title: Helv. Chim. Acta
  doi: 10.1002/hlca.19850680319
  contributor:
    fullname: Loosli
– volume: 35
  start-page: 83
  year: 2010
  ident: 10.1016/j.bmc.2016.05.062_b0025
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2009.06.016
  contributor:
    fullname: Domes
– volume: 58
  start-page: 639
  year: 2008
  ident: 10.1016/j.bmc.2016.05.062_b0015
  publication-title: Neuron
  doi: 10.1016/j.neuron.2008.04.009
  contributor:
    fullname: Baumgartner
– volume: 5
  start-page: 1167
  year: 2014
  ident: 10.1016/j.bmc.2016.05.062_h0090
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/ml500239m
  contributor:
    fullname: Goetz
– volume: 58
  start-page: 4581
  year: 2015
  ident: 10.1016/j.bmc.2016.05.062_h0130
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b00128
  contributor:
    fullname: Bockus
– volume: 55
  start-page: 383
  year: 2004
  ident: 10.1016/j.bmc.2016.05.062_b0115
  publication-title: Proteins
  doi: 10.1002/prot.20033
  contributor:
    fullname: Onufriev
– volume: 32
  start-page: 426
  year: 2011
  ident: 10.1016/j.bmc.2016.05.062_b0005
  publication-title: Front. Neuroendocrinol.
  doi: 10.1016/j.yfrne.2011.07.001
  contributor:
    fullname: Striepens
– volume: 235
  start-page: PC64
  year: 1960
  ident: 10.1016/j.bmc.2016.05.062_h0180
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)64530-2
  contributor:
    fullname: du Vigneaud
– volume: Vol. 170
  start-page: 473
  year: 2008
  ident: 10.1016/j.bmc.2016.05.062_h0190
  article-title: Peptide and Non-Peptide Agonists and Antagonists for the Vasopressin and Oxytocin V1a, V1b, V2 and OT Receptors: Research Tools and Potential Therapeutic Agents
  contributor:
    fullname: Manning
– volume: 8
  start-page: 479
  year: 2011
  ident: 10.1016/j.bmc.2016.05.062_h0120
  publication-title: Mol. Pharm.
  doi: 10.1021/mp1003306
  contributor:
    fullname: Ovadia
– volume: 2
  start-page: 669
  year: 2011
  ident: 10.1016/j.bmc.2016.05.062_h0125
  publication-title: MedChemComm
  doi: 10.1039/c1md00093d
  contributor:
    fullname: Alex
– volume: 134
  start-page: 12125
  year: 2012
  ident: 10.1016/j.bmc.2016.05.062_h0115
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja303200d
  contributor:
    fullname: Beck
– volume: 28
  start-page: 193
  year: 2003
  ident: 10.1016/j.bmc.2016.05.062_h0045
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300021
  contributor:
    fullname: Hollander
– volume: 3
  start-page: 537
  year: 1990
  ident: 10.1016/j.bmc.2016.05.062_b0110
  publication-title: Tetrahedron Comput. Methodol.
  doi: 10.1016/0898-5529(90)90156-3
  contributor:
    fullname: Gasteiger
– volume: 2
  start-page: e1128
  year: 2007
  ident: 10.1016/j.bmc.2016.05.062_h0025
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0001128
  contributor:
    fullname: Zak
– volume: 93
  start-page: 2184
  year: 2004
  ident: 10.1016/j.bmc.2016.05.062_b0050
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.20125
  contributor:
    fullname: Tang
– volume: 3
  start-page: 653
  year: 1993
  ident: 10.1016/j.bmc.2016.05.062_h0170
  publication-title: J. Biomol. NMR
  doi: 10.1007/BF00198370
  contributor:
    fullname: Kato
– volume: 48
  start-page: 6553
  year: 2005
  ident: 10.1016/j.bmc.2016.05.062_h0200
  publication-title: J. Med. Chem.
  doi: 10.1021/jm049205z
  contributor:
    fullname: Wittelsberger
– volume: 19
  start-page: 165
  year: 2005
  ident: 10.1016/j.bmc.2016.05.062_h0070
  publication-title: BioDrugs
  doi: 10.2165/00063030-200519030-00003
  contributor:
    fullname: Hamman
– volume: 32
  start-page: 1599
  year: 1992
  ident: 10.1016/j.bmc.2016.05.062_h0160
  publication-title: Biopolymers
  doi: 10.1002/bip.360321203
  contributor:
    fullname: Bhaskaran
– volume: 68
  start-page: 956
  year: 1971
  ident: 10.1016/j.bmc.2016.05.062_h0175
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.68.5.956
  contributor:
    fullname: Urry
– volume: 47
  start-page: 2595
  year: 2008
  ident: 10.1016/j.bmc.2016.05.062_h0135
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.200705797
  contributor:
    fullname: Biron
– volume: 48
  start-page: 168
  year: 2010
  ident: 10.1016/j.bmc.2016.05.062_h0155
  publication-title: Magn. Reson. Chem.
  contributor:
    fullname: Ohno
– volume: 57
  start-page: 2920
  year: 2014
  ident: 10.1016/j.bmc.2016.05.062_h0095
  publication-title: J. Med. Chem.
  doi: 10.1021/jm401859b
  contributor:
    fullname: Goetz
– volume: 17
  start-page: 4443
  year: 1978
  ident: 10.1016/j.bmc.2016.05.062_h0165
  publication-title: Biochemistry
  doi: 10.1021/bi00614a014
  contributor:
    fullname: Ballardin
SSID ssj0002491
Score 2.3666859
Snippet [Display omitted] Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding,...
Oxytocin (OT) is a peptide hormone agonist of the OT receptor (OTR) that plays an important role in social behaviors such as pair bonding, maternal bonding and...
Source Web of Science
SourceID proquest
crossref
pubmed
webofscience
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3513
SubjectTerms Biochemistry & Molecular Biology
Chemistry
Chemistry, Medicinal
Chemistry, Organic
Cyclic peptide
Hidden polarity
Hydrogen Bonding
Intramolecular hydrogen bond
Life Sciences & Biomedicine
Magnetic Resonance Spectroscopy
Methylation
NMR
Oxytocin
Oxytocin - chemistry
Peptide
Pharmacology & Pharmacy
Physical Sciences
Polarity
Science & Technology
SFC
Structure-Activity Relationship
Temperature
Title Systematic N-methylation of oxytocin: Impact on pharmacology and intramolecular hydrogen bonding network
URI https://dx.doi.org/10.1016/j.bmc.2016.05.062
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000380515700020
https://www.ncbi.nlm.nih.gov/pubmed/27297999
https://search.proquest.com/docview/1805766976
Volume 24
WOS 000380515700020
WOSCitedRecordID wos000380515700020
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SBNpeSrvpw30EFUIPBXdlr621eluWhk1Lc0kDuQk9bLKBtZfUgewlv72fZHvb0gelF4PlB7I-eeYbzWiG6DDRFUgD_m8jbRZnU2FiKWGlWF7BfNaVEWWI8j0Ri7Ps43l-vkPzYS-MD6vsZX8n04O07lvG_WiO18vl-BTku-CFFGAUmIkCdvse1JH31e7Njj8tTrYCGRZGKJyH-2P_wODcDGFeZuUTGSYi5O8U6Z_U06_087eaKmilo4f0oKeTbNb1-BHtlPWI9mc1TOnVhr1hIcAzrJyP6N58KO42orufe5_6Pl2cbpM5M4jVEsh18XGsqVhzs2kBX_2eHYftlAzN6-_ZrjdM144t_QLxaqizyy427qrBvGSmCVtmWN2Fmj-ms6MPX-aLuK-_ENsskW1cGZ5qDrSsldoJ7g8O2OYuM979VyVSFzZHQybtxLlKg1_kMJAK0DqX2skT2q2bunxGjMvUCKNtakvwCbydywmv8Ho9BUObuIjeDsOu1l2aDTXEn10qYKQ8RornChhFlA3AqJ_mioIa-NtjrwcQFUbbO0Z0XTbXX1VSgLUKAWYW0dMO3W0vUlgfU7DoiA5_hHt7PfhWfaGcafDqRpT8y23zPgG7TzzQPv-_73lB9_2ZX-BO8pe0215dl6_AkFpzQHfe3SYH_X_wDeE2DoQ
link.rule.ids 314,780,784,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCk0vpd304T5VCD0U3JW9ttbqLSwNmzbJJQnkJvSwyQbWXlIHupf-9n6S7U1LH5RefJBlIesbSd9oRjNEe4muQBowv420WZxNhYmlhJZieQX1WVdGlMHL90TMz7NPF_nFFs2GuzDerbJf-7s1PazWfcm4H83xarEYn4J8F7yQAowCkiigt9_JcrBfCPX7b7d-HtAvQto81I599cG0GZy8zNKHMUxEiN4p0j9tTr-Sz9_uU2FPOnhA93syyfa7_j6krbIe0e5-DUV6uWZvWXDvDOfmI9qZDandRnT3uLeo79Ll6SaUM8OiWgK3zjuONRVrvq5bgFd_YIfhMiVD8eo21vWa6dqxhT8eXg5Zdtnl2l03kEpmmnBhhtWdo_kjOj_4eDabx332hdhmiWzjyvBUc2BlrdROcP9wQDZ3mfHGvyqRurA5CjJpJ85VGuwih3pUgNS51E4e03bd1OVTYlymRhhtU1uCTaB1Lie8QvN6Cn42cRG9G4ZdrbogG2rwPrtSwEh5jBTPFTCKKBuAUT9JisIm8LfP3gwgKoy2N4voumxuvqikAGcVArwsoicduptepNA9puDQEe39CPfmfbCs-jQ502DTjSj5l2qzPvy6DzvQPvu__3lNO_Oz4yN1dHjy-Tnd82_8UXeSv6Dt9vqmfAmu1JpXYS58B1cRD10
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systematic+N-methylation+of+oxytocin%3A+Impact+on+pharmacology+and+intramolecular+hydrogen+bonding+network&rft.jtitle=Bioorganic+%26+medicinal+chemistry&rft.au=Sciabola%2C+Simone&rft.au=Goetz%2C+Gilles+H.&rft.au=Bai%2C+Guoyun&rft.au=Rogers%2C+Bruce+N.&rft.date=2016-08-15&rft.pub=Elsevier&rft.issn=0968-0896&rft.eissn=1464-3391&rft.volume=24&rft.issue=16&rft.spage=3513&rft.epage=3520&rft_id=info:doi/10.1016%2Fj.bmc.2016.05.062&rft_id=info%3Apmid%2F27297999&rft.externalDBID=n%2Fa&rft.externalDocID=000380515700020
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0968-0896&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0968-0896&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0968-0896&client=summon